Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Sciadopitysin: active component from Taxus chinensis for anti-Alzheimer's disease.

Gu Q, Li Y, Chen Y, Yao P, Ou T.

Nat Prod Res. 2013;27(22):2157-60. doi: 10.1080/14786419.2013.790031. Epub 2013 Apr 29.

PMID:
23627438
2.

Silibinin: a novel inhibitor of Aβ aggregation.

Yin F, Liu J, Ji X, Wang Y, Zidichouski J, Zhang J.

Neurochem Int. 2011 Feb;58(3):399-403. doi: 10.1016/j.neuint.2010.12.017. Epub 2010 Dec 24.

PMID:
21185897
3.

3,5-Diarylpyrazole Derivatives Obtained by Ammonolysis of the Total Flavonoids from Chrysanthemum indicum Extract Show Potential for the Treatment of Alzheimer's Disease.

Wu T, Jiang C, Wang L, Morris-Natschke SL, Miao H, Gu L, Xu J, Lee KH, Gu Q.

J Nat Prod. 2015 Jul 24;78(7):1593-9. doi: 10.1021/acs.jnatprod.5b00156. Epub 2015 Jun 23.

PMID:
26099993
4.

Salvianic borneol ester reduces β-amyloid oligomers and prevents cytotoxicity.

Han M, Liu Y, Zhang B, Qiao J, Lu W, Zhu Y, Wang Y, Zhao C.

Pharm Biol. 2011 Oct;49(10):1008-13. doi: 10.3109/13880209.2011.559585.

PMID:
21936627
5.

Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's Disease.

Thapa A, Chi EY.

Adv Exp Med Biol. 2015;863:55-77. doi: 10.1007/978-3-319-18365-7_3. Review.

PMID:
26092626
6.

Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells.

Wang Q, Yu X, Patal K, Hu R, Chuang S, Zhang G, Zheng J.

ACS Chem Neurosci. 2013 Jun 19;4(6):1004-15. doi: 10.1021/cn400051e. Epub 2013 Mar 29.

7.

Leaf and stem of Vitis amurensis and its active components protect against amyloid β protein (25-35)-induced neurotoxicity.

Jeong HY, Kim JY, Lee HK, Ha do T, Song KS, Bae K, Seong YH.

Arch Pharm Res. 2010 Oct;33(10):1655-64. doi: 10.1007/s12272-010-1015-6. Epub 2010 Oct 30.

PMID:
21052941
8.

Neuroprotective effects of naturally occurring biflavonoids.

Kang SS, Lee JY, Choi YK, Song SS, Kim JS, Jeon SJ, Han YN, Son KH, Han BH.

Bioorg Med Chem Lett. 2005 Aug 1;15(15):3588-91.

PMID:
15978805
9.

Inhibitory effects of Glycyrrhizae radix and its active component, isoliquiritigenin, on Aβ(25-35)-induced neurotoxicity in cultured rat cortical neurons.

Lee HK, Yang EJ, Kim JY, Song KS, Seong YH.

Arch Pharm Res. 2012 May;35(5):897-904. doi: 10.1007/s12272-012-0515-y. Epub 2012 May 29.

PMID:
22644857
10.

Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease.

Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K, Saido TC, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H.

PLoS One. 2011;6(9):e25788. doi: 10.1371/journal.pone.0025788. Epub 2011 Sep 30.

11.

Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.

De Felice FG, Vieira MN, Saraiva LM, Figueroa-Villar JD, Garcia-Abreu J, Liu R, Chang L, Klein WL, Ferreira ST.

FASEB J. 2004 Sep;18(12):1366-72.

PMID:
15333579
12.

Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity.

Thapa A, Vernon BC, De la Peña K, Soliz G, Moreno HA, López GP, Chi EY.

Langmuir. 2013 Sep 17;29(37):11713-23. doi: 10.1021/la4020459. Epub 2013 Sep 4.

PMID:
24004419
13.

Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.

Matharu B, El-Agnaf O, Razvi A, Austen BM.

Peptides. 2010 Oct;31(10):1866-72. doi: 10.1016/j.peptides.2010.06.033. Epub 2010 Jul 13.

PMID:
20633587
14.

The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.

Amijee H, Bate C, Williams A, Virdee J, Jeggo R, Spanswick D, Scopes DI, Treherne JM, Mazzitelli S, Chawner R, Eyers CE, Doig AJ.

Biochemistry. 2012 Oct 23;51(42):8338-52. doi: 10.1021/bi300415v. Epub 2012 Oct 12.

PMID:
23025847
15.

Xylocoside G reduces amyloid-β induced neurotoxicity by inhibiting NF-κB signaling pathway in neuronal cells.

Yu Y, Zhou L, Sun M, Zhou T, Zhong K, Wang H, Liu Y, Liu X, Xiao R, Ge J, Tu P, Fan DS, Lan Y, Hui C, Chui D.

J Alzheimers Dis. 2012;30(2):263-75. doi: 10.3233/JAD-2012-110779.

PMID:
22430528
16.

Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.

Han M, Liu Y, Tan Q, Zhang B, Wang W, Liu J, Zhang XJ, Wang YY, Zhang JM.

Eur J Pharmacol. 2011 Apr 25;657(1-3):104-10. doi: 10.1016/j.ejphar.2011.01.065. Epub 2011 Feb 17.

PMID:
21316359
17.

Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.

Schuster D, Rajendran A, Hui SW, Nicotera T, Srikrishnan T, Kruzel ML.

Neuropeptides. 2005 Aug;39(4):419-26.

PMID:
15890402
18.

Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.

Croce N, Dinallo V, Ricci V, Federici G, Caltagirone C, Bernardini S, Angelucci F.

Neurodegener Dis. 2011;8(5):300-9. doi: 10.1159/000323468. Epub 2011 Feb 23.

PMID:
21346312
19.

Inhibiting β-amyloid-associated Alzheimer's pathogenesis in vitro and in vivo by a multifunctional dimeric bis(12)-hupyridone derived from its natural analogue.

Hu S, Wang R, Cui W, Zhang Z, Mak S, Xu D, Choi C, Tsim KW, Carlier PR, Lee M, Han Y.

J Mol Neurosci. 2015 Apr;55(4):1014-21. doi: 10.1007/s12031-014-0458-5. Epub 2014 Nov 19.

PMID:
25407821
20.

Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease.

O'Hare E, Scopes DI, Kim EM, Palmer P, Spanswick D, McMahon B, Amijee H, Nerou E, Treherne JM, Jeggo R.

Int J Neuropsychopharmacol. 2014 Jan;17(1):117-26. doi: 10.1017/S1461145713000886. Epub 2013 Oct 8.

PMID:
24103729

Supplemental Content

Support Center